Skip to main content
OpenTrials
Completed

NCT Number: NCT05935280

Mechanism of Human Cold Pain Perception - Involvement of TRPA1, TRPM8, Nav1.7 and Nav1.8

Animal studies suggest that the transient receptor potential ion channels TRPM8 and TRPA1 are cold sensors and that sodium channels Nav1.8 and Nav1.7 are essential for detecting pain induced by cold temperatures. This study aims to validate these findings in humans.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Medical University of Vienna

Vienna, 1090, Austria

About this study

It is essential for human survival to be able to perceive potentially harmful cold. The perception of slight cooling in animals depends on the ion channel TRPM8, but this may represent a largely separate mechanism from painful cold. In mice, TRPM8 and TRPA1 appear to be involved, but also the sodium channels Nav1.7 and Nav1.8, through their temperature-dependent function. These receptors might be redundant, so that failure of individual receptors only leads to no or only a partial reduction in the detection of cold.

Since results obtained in animals do not always translate to humans, the investigators want to clarify whether TRPM8, TRPA1, Nav1.7 and Nav1.8 are involved in the perception of cold pain in humans.

In order to induce cold pain experimentally, an increasingly cooled solution (down to 3°C) is injected into the skin, and the inhibitors for the mentioned targets are added individually and in combination.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 70 years
  • Full legal capacity

To ensure an equal number of each sex in the study population, only volunteers of one sex will be included as soon as the number of subjects with the other sex has reached half of the calculated sample size.

Exclusion criteria

  • Participant of another study, ongoing or within the last 4 weeks
  • Medication intake (except contraception) or drug abuse
  • Female subjects: Positive pregnancy test or breastfeeding
  • Body temperature above 38°C, diagnostically verified
  • Known allergic diseases, in particular asthmatic disorders and skin diseases
  • Sensory deficit, skin disease or hematoma of unknown origin in physical examination of the test site

Treatment and study plan

Room temperature

Other

Room temperature injection

Cold temperature

Other

Cold temperature injection

Lidocain

Drug

Unspecific sodium channel blocker

Other names: Unspecific sodium channel blocker

PF-05105679

Drug

Specific antagonist of the TRPM8 ion channel

Other names: Specific TRPM8 antagonist

A967079

Drug

Specific antagonist of the TRPA1 ion channel

Other names: Specific TRPA1 antagonist

PF-05089771

Drug

Specific antagonist of the Nav1.7 sodium channel

Other names: Specific Nav1.7 antagonist

PF-06305591

Drug

Specific antagonist of the Nav1.8 sodium channel

Other names: Specific Nav1.8 antagonist

Primary outcomes

  1. AUC Pain3°C

    Time frame: Through study completion, on average 90 minutes.

    The primary outcome variable is the area under the curve (AUC) of pain ratings over a limited duration of the infusion period, i.e. from 120-150 seconds (last 30 seconds of the cold stimulus).

Secondary outcomes

  1. AUC Pain

    Time frame: Through study completion, on average 90 minutes.

    The secondary outcome variable is the area under the curve (AUC) of pain ratings over the full duration of the infusion period (full 150 seconds of the cold stimulus).

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Human Cold Pain - a Single-group, Randomized, Placebo-controlled, Adaptive, Factorial Crossover Trial

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jul 7, 2023
Registry last updated
Mar 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.